
ACRS
USDAclaris Therapeutics Inc. Common Stock
$2.360-0.140 (-5.600%)
Real-time Price
Healthcare
Biotechnology
United States
Price Chart
Loading Chart...
Key Metrics
Market Metrics
Open
$2.500
High
$2.599
Low
$2.315
Volume
3.54M
Company Fundamentals
Market Cap
255.7M
Industry
Biotechnology
Country
United States
Trading Stats
Avg Volume
1.05M
Exchange
NMS
Currency
USD
52-Week Range
Low $1.05Current $2.360High $5.17
Related News
GlobeNewswire
Aclaris Therapeutics to Participate in Three November Healthcare Conferences
WAYNE, Pa., Oct. 29, 2025 (GLOBE NEWSWIRE) -- Aclaris Therapeutics, Inc. (NASDAQ:ACRS), a clinical-stage biopharmaceutical company focused on developing novel product candidates for immuno-inflammatory diseases, today
View more
Related Stocks
SSYS
Stratasys Ltd. Ordinary Shares (Israel)
NASDAQ
Computer periph...
COUR
Coursera Inc.
NASDAQ
Computer Softwa...
LFT
Lument Finance Trust Inc.
NASDAQ
Real Estate Inv...
EVI
EVI Industries Inc.
NASDAQ
Other Consumer ...
ELC
Entergy Louisiana Inc. Collateral Trust Mortgage Bonds 4.875 % Series due September 1 2066
NASDAQ
Electric Utilit...
Stay Updated
Set price alerts, get AI analysis updates and real-time market news.